60 Degrees Pharmaceuticals, Inc. Share Price
NASDAQ: SXTP | Micro Cap60 Degrees Pharmaceuticals, Inc. Stock Performance
Open $1.08 | Prev. Close $1.06 | Circuit Range N/A |
Day Range $1.08 - $1.08 | Year Range $0.40 - $8.22 | Volume 100 |
Average Traded $1.08 |
60 Degrees Pharmaceuticals, Inc. Share Price Today
As of 30 August 2026, 60 Degrees Pharmaceuticals, Inc.'s share price is $1.08. The stock opened at $1.08, compared to its previous close of $1.06. During today's trading session, 60 Degrees Pharmaceuticals, Inc.'s share price traded between $1.08 and $1.08, with an average price of $1.08. Over the past 52 weeks, the stock has recorded a high of $8.22 and a low of $0.40. In terms of performance, 60 Degrees Pharmaceuticals, Inc.'s share price has declined by 62.89% over the last six months and is down 22.86% on a year-on-year basis.
60 Degrees Pharmaceuticals, Inc. Share Price Chart
60 Degrees Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $490948.56 | PE Ratio (TTM) -0.06 | Dividend Yield N/A |
EPS (TTM) $-18.55 | Revenue (TTM) $73771.00 | Return On Equity (TTM) -229.72% |
Profit Margin -10784.27% | Debt to Equity 0.53 | Quarterly Earnings Growth YoY -7.25% |
60 Degrees Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
60 Degrees Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
60 Degrees Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.14 | $1.06 | -4.48% |
Jul 2026 | $1.87 | $1.11 | -30.75% |
Jun 2026 | $1.49 | $1.61 | +7.69% |
May 2026 | $1.67 | $1.50 | -5.68% |
Apr 2026 | $1.74 | $1.58 | -8.65% |
Mar 2026 | $2.72 | $1.74 | -40.38% |
Feb 2026 | $3.62 | $2.91 | -31.37% |
Jan 2026 | $0.52 | $4.24 | +733.01% |
Dec 2025 | $1.09 | $0.51 | -48.59% |
Nov 2025 | $1.32 | $0.99 | -27.21% |
Oct 2025 | $1.48 | $1.36 | -6.21% |
Sep 2025 | $1.38 | $1.45 | +3.57% |
SXTP Share Price FAQs
What is 60 Degrees Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of 60 Degrees Pharmaceuticals, Inc. stock?
What is SXTP's market capitalisation today?
What is SXTP's net income for the last quarter?
What is the 5 year returns of SXTP?
What is the high & low stock price of SXTP today?
Can I buy SXTP shares in India?